Morgan Stanley Reiterates “Overweight” Rating for Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH)‘s stock had its “overweight” rating restated by investment analysts at Morgan Stanley in a report issued on Wednesday,Benzinga reports. They currently have a $485.00 price objective on the stock.

OPCH has been the subject of a number of other research reports. JPMorgan Chase & Co. reduced their price objective on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday. UBS Group dropped their target price on Option Care Health from $45.00 to $39.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Stephens set a $30.00 price target on Option Care Health in a research report on Friday, May 1st. National Bank Financial set a $37.00 price objective on Option Care Health in a research note on Tuesday, January 27th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $26.00 price objective on shares of Option Care Health in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $69.33.

Option Care Health Stock Down 2.2%

NASDAQ:OPCH traded down $0.47 during mid-day trading on Wednesday, reaching $20.84. The company’s stock had a trading volume of 2,853,888 shares, compared to its average volume of 2,197,329. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The stock has a fifty day moving average of $28.86 and a 200-day moving average of $30.70. The firm has a market capitalization of $3.27 billion, a PE ratio of 16.15, a price-to-earnings-growth ratio of 1.21 and a beta of 0.68.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.39 billion. During the same quarter in the previous year, the business posted $0.40 EPS. The company’s quarterly revenue was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities research analysts forecast that Option Care Health will post 1.69 earnings per share for the current year.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average cost of $21.41 per share, with a total value of $783,820.10. Following the transaction, the director directly owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. This represents a 8.86% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO John Charles Rademacher purchased 12,500 shares of the firm’s stock in a transaction on Monday, May 4th. The stock was acquired at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the purchase, the chief executive officer owned 695,152 shares of the company’s stock, valued at $14,723,319.36. The trade was a 1.83% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently modified their holdings of OPCH. Royal Bank of Canada increased its stake in Option Care Health by 20.7% during the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after purchasing an additional 39,661 shares in the last quarter. AQR Capital Management LLC lifted its stake in shares of Option Care Health by 162.6% during the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after buying an additional 25,777 shares during the period. Empowered Funds LLC acquired a new stake in shares of Option Care Health during the first quarter worth $208,000. Invesco Ltd. lifted its stake in shares of Option Care Health by 2.7% during the second quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock worth $9,561,000 after buying an additional 7,678 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.